Verrica Pharmaceuticals Dirección
Dirección controles de criterios 2/4
El CEO de Verrica Pharmaceuticals es Jayson Rieger, nombrado en Nov 2024, tiene una permanencia de 8.92 años. posee directamente un 1.23% de las acciones de la empresa, con un valor de $553.39K. La antigüedad media del equipo directivo y de la junta directiva es de 4.3 años y 7.7 años, respectivamente.
Información clave
Jayson Rieger
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | no data |
| Participación del CEO | 1.2% |
| Permanencia media de la dirección | 4.3yrs |
| Promedio de permanencia en la Junta Directiva | 7.7yrs |
Actualizaciones recientes de la dirección
Recent updates
The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%
Oct 03
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 17With A 67% Price Drop For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) You'll Still Get What You Pay For
Aug 16Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?
Jul 21Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?
Jan 11Here's Why We're Not At All Concerned With Verrica Pharmaceuticals' (NASDAQ:VRCA) Cash Burn Situation
Jun 28We're Hopeful That Verrica Pharmaceuticals (NASDAQ:VRCA) Will Use Its Cash Wisely
Feb 05Vectoring Back In On Verrica Pharmaceuticals
Aug 31Verrica Pharmaceuticals reports insider buying
Jul 06Verrica Pharmaceuticals stock slides on proposed share offering
Jun 29Verrica Pharmaceuticals Should Receive Second CRL Today
May 24CEO
Jayson Rieger (48 yo)
no data
Permanencia
Dr. Jayson M. Rieger, Ph D., M.B.A., is President, CEO & Director of Verrica Pharmaceuticals Inc. from November 5, 2024. Dr. Rieger serves as Non-Executive Independent Director at Lytix Biopharma AS since...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chief Legal Officer | 6.2yrs | US$2.56m | 0.14% $ 65.1k | |
| President | no data | sin datos | 1.23% $ 553.4k | |
| Interim CFO | no data | sin datos | sin datos | |
| Chief Medical Officer | 4.3yrs | US$989.18k | 0.12% $ 53.7k | |
| Executive Vice President of Technical Operations | 5.1yrs | sin datos | sin datos | |
| Head of Drug Development | 4.3yrs | sin datos | sin datos |
4.3yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de VRCA se considera experimentado (4.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 8.9yrs | sin datos | 1.23% $ 553.4k | |
| Independent Director | 6.5yrs | US$119.19k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 4.3yrs | US$119.19k | 0% $ 0 | |
| Director | 8.9yrs | sin datos | 1.01% $ 457.5k | |
| Chairman of the Board | 8.9yrs | sin datos | 29.71% $ 13.4m | |
| Director | 6.5yrs | US$3.50m | 0.23% $ 102.4k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
7.7yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de VRCA se considera experimentada (7.7 años de antigüedad promedio).